Ublituximab and ibrutinib for previously treated genetically high-risk chronic lymphocytic leukemia: Results of the GENUINE Phase 3 study

Drug Category: Array
Conference Category: Array
Lead Author: Mato A, et al.
Published Date: 16/06/2017
Download Link: /wp-content/uploads/2019/03/Final%20GENUINE%20ICML%202017%20Mato.PDF
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top